معرفی
Professor Alexander Bobik is an internationally recognized vascular biologist with 40 years of research experience in vascular biology and cardiovascular disease, particularly focusing on atherosclerosis. He holds the position of Adjunct Professor (Research) in Immunology at Monash University, affiliated with the Alfred Hospital Centre for Inflammatory Disease and Monash Health. His work has led to over 225 publications, including seminal studies on the role of immune cells (e.g., B cells, CD8 T cells) in atherosclerosis pathogenesis. He co-led a National Health and Medical Research Council-funded project (2011–2013) investigating B lymphocytes in atherosclerosis.
Research interests include immunopathogenesis of atherosclerosis, hypertension, and the interplay between immune cells and vascular disease. Notable contributions include demonstrating proatherogenic roles of B2 cells and CD8 T cells, while B1a cells and regulatory T cells exhibit protective effects. His findings have redefined understanding of B cell contributions to atherosclerosis.
Bobik serves on 12 editorial boards of biomedical journals, including Arteriosclerosis Thrombosis and Vascular Biology. He has supervised numerous postgraduate students and postdoctoral fellows globally. His research aligns with UN Sustainable Development Goals related to health and well-being.
Key grants include the NHMRC-funded project on B lymphocytes in atherosclerosis. His work emphasizes translational research, identifying therapeutic targets like Factor XIIa inhibition and proteomic signatures for plaque stabilization. Collaborations span international institutions, focusing on immune mechanisms in cardiovascular diseases.
